Search

everythinglearnresearchcommunity

for

Search:↓

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

Sex hormones, especially androgens, play a key role in causing acne.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

Semaglutide helps obese PCOS patients lose weight and improve health.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Gender differences affect allergy prevalence, severity, and response to environmental toxins, with women often more affected than men.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

The study found that the hair loss condition in Cesky Fousek dogs is influenced by multiple genes affecting skin and muscle structure, fat metabolism, and immunity.

Goat genes show adaptation to environments and traits like body development, with differences among cashmere, feral, and milk-producing goats.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Hormonal therapies effectively treat acne and improve quality of life.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

The document discusses how to diagnose and treat conditions like acne, excessive hair growth, and female pattern hair loss related to hormone imbalances.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

High doses of norethindrone acetate in rats caused various organ changes but didn't significantly increase tumor rates.

Certain hormone treatments can increase SBP levels and help with mild body hair growth.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Inhibiting 5α-reductase during late pregnancy shortens gestation, reduces litter size, and harms memory in rat offspring.